CTI BIOPHARMA CORP·4

Oct 3, 3:16 PM ET

SINGER JACK W 4

4 · CTI BIOPHARMA CORP · Filed Oct 3, 2017

Insider Transaction Report

Form 4
Period: 2017-09-29
SINGER JACK W
EVP, Chief Medical Officer
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2017-09-29+115,000115,000 total
    Exercise: $3.19Exp: 2027-09-29Common Stock (115,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest in six equal semi-annual installments over a three-year period beginning September 29, 2017 subject to continued employment by CTIC through the applicable vesting dates.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT